
News|Articles|January 20, 2026
Supplements And Featured Publications
- The Broader Impact of GEMTESA® (vibegron) in Addressing OAB in Men Receiving BPH Therapy
The Broader Impact of GEMTESA® (vibegron) in Addressing OAB in Men Receiving BPH Therapy
Sponsored by Sumitomo Pharma America, Inc.
Trending on Managed Healthcare Executive
1
A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends
2
Langlara, third interchangeable biosimilar to Lantus, approved by FDA
3
Cancer patients taking GLP-1s less likely to develop advanced disease | ASCO 2026
4
FDA approves first treatment for chronic hepatitis D virus
5


























